+44 (0) 1223 755950
+1 832 327 7413
Ravagalimab
REQUEST MORE INFO
Catalogue No: abx831470
Price:
US$435.00
(Size: 100 µg)
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
Ravagalimab is a humanized monoclonal antibody biosimilar expressed in CHO cells, targeting CD40/TNFRSF, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Research Articles on CD40/TNFRSF
| Target | CD40/TNFRSF |
| Clonality | Monoclonal |
| Reactivity | Human |
| Expression | Recombinant |
| Tested Applications | ELISA, WB, SDS-PAGE |
| Host | CHO cells |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Isotype | IgG1 Kappa |
| Form | Liquid |
| Purity | > 95% |
| Purification | Purified from cell culture supernatants by Protein A/G chromatography. |
| Storage | Store at 4 °C if the entire vial will be used within 1-2 weeks. Aliquot and store at -20 °C or -80 °C for long term storage. Avoid repeated freeze/thaw cycles. |
| Buffer | 30 mM Histidine, pH 5.8, containing 10% sucrose, 0.02% Tween. |
| CAS Number | 2050816-56-1 |
| Concentration | 0.78 mg/ml |
| Availability | Shipped within 7-12 working days. |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |